Isabelle Lelong-Rebel

Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells <i>In vivo</i> and <i>In vitro</i> Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis

Erwan Pencreach, Éric Guérin, Céline Nicolet et al. · Clinical Cancer Research · 2009 · 80 citations

Medicine, Oncology, Pharmacology +15

Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma

Guillaume Renner, Hana Janoušková, Fanny Noulet et al. · Cell Death and Differentiation · 2015 · 69 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells

Guillaume Renner, Fanny Noulet, Marie-Cécile Mercier et al. · Oncotarget · 2016 · 49 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells

Hana Janoušková, Anne‐Marie Ray, Fanny Noulet et al. · Cancer Letters · 2013 · 46 citations

Life Sciences, Cell Biology, Oncology +14

RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma

Pierre Fechter, Elisabete Cruz Da Silva, Marie-Cécile Mercier et al. · Molecular Therapy — Nucleic Acids · 2019 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +15